BMY earnings: next report 2026-07-30, real EPS beat/miss history, analyst consensus Hold, P/E 17.07. Updated 2026-07-23.
Bristol-Myers Squibb (BMY) Research Hub
Bristol-Myers Squibb (BMY) trades on NYSE, US in the Healthcare (Drug Manufacturers - General) sector. As of 2026-09-11, shares last closed at 63.64 USD (-1.20%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 17.07, market cap 124.29B. This hub links to the full technical, earnings and options research available for BMY.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - General) |
|---|---|
| Exchange | NYSE, US |
| Last close | 63.64 USD (-1.20%) |
| 52-week range | 54 USD – 68.64 USD |
| Trend regime | Range |
| 14-day RSI | 46.1 (Neutral) |
| Trailing P/E | 17.07 |
| Market cap | 124.29B |
| Dividend yield | 4.13% |
| Next earnings | 2026-07-30 |
Available research for BMY
Covered Call on BMY: how it works, illustrative setup around the real 63.64 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on BMY: how it works, illustrative setup around the real 63.64 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on BMY: how it works, illustrative setup around the real 63.64 USD price, max profit/loss, breakeven and when to use it. Educational.
BMY technical analysis: range, last 63.64 USD, RSI 46.1, 52w range 54 USD–68.64 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is BMY in?
Bristol-Myers Squibb (BMY) is classified under Healthcare (Drug Manufacturers - General), listed on NYSE, US.
Is BMY in an uptrend or downtrend?
As of 2026-09-11, BMY is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is BMY's trailing P/E ratio?
BMY's trailing P/E is 17.07, with a market cap of 124.29B. See the earnings research page for full valuation detail.
When does BMY next report earnings?
BMY is next scheduled to report earnings on 2026-07-30, with a consensus EPS estimate of 1.6 USD.